High-Density Lipoprotein Modifications: A Pathological Consequence or Cause of Disease Progression?

Area of Science:

• Biochemistry
• Cardiovascular Science
• Metabolic Disorders

Background:

• High-density lipoprotein (HDL) is recognized for its cardioprotective effects, including anti-inflammatory and anti-oxidative properties.
• Traditional focus on increasing HDL cholesterol levels is shifting towards understanding HDL composition and functionality.
• Dysfunctional HDL is observed in conditions like chronic kidney disease and cardiovascular diseases.

Purpose of the Study:

• To review key modifications of HDL.
• To investigate whether HDL modifications are a consequence or a cause of pathology.
• To explore HDL composition as a potential therapeutic target.

Main Methods:

• Literature review of HDL modifications.
• Analysis of the role of HDL composition in disease pathogenesis.
• Discussion of specific HDL protein modifications (e.g., oxidation, carbamylation, glycation).

Main Results:

• HDL functionality, not cholesterol levels, is a more critical target.
• Various modifications like serum amyloid, oxidation, carbamylation, and glycation alter HDL function.
• Changes in HDL-associated enzymes (CETP, LCAT, PLTP) impact its composition and role.

Conclusions:

• HDL composition is significantly altered in pathological conditions.
• Further research is needed to determine the causal role of HDL modifications in disease development.
• Targeting HDL composition may offer a novel therapeutic strategy for various diseases.